SCHEMBL6599744

SCHEMBL6599744

Cc1ccc(-c2ccc(C=Cc3cc(C(F)(F)F)[nH]c(=O)n3)o2)cc1C(=O)O

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.69
KDM4E B2RXH2 8/20 0.69
KMT2A Q03164 7/20 0.69
MEN1 O00255 6/20 0.69
POLB P06746 5/20 0.69
USP2 O75604 2/20 0.69
HTT P42858 2/20 0.69
RECQL P46063 1/20 0.69
TLR9 Q9NR96 1/20 0.69
MAPT P10636 6/20 0.67
LMNA P02545 3/20 0.67
HPGD P15428 2/20 0.67
L3MBTL1 Q9Y468 3/20 0.67
CRHBP P24387 1/20 0.67
CRHR2 Q13324 1/20 0.67
PSD A5PKW4 1/20 0.63
TNF P01375 3/20 0.43
NOD1 Q9Y239 3/20 0.43
RAB9A P51151 1/20 0.43
GAA P10253 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6599741 1.00 ALDH1A1 (0.69) ALDH1A1KDM4EKMT2AMEN1POLB
SCHEMBL6591443 0.90 MEN1 (0.70) ALDH1A1KDM4EKMT2AMEN1POLB
SCHEMBL6591439 0.90 MEN1 (0.70) ALDH1A1KDM4EKMT2AMEN1POLB
SCHEMBL6593389 0.89 KMT2A (0.72) ALDH1A1KDM4EKMT2AMEN1POLB
SCHEMBL6593384 0.89 KMT2A (0.72) ALDH1A1KDM4EKMT2AMEN1POLB
SCHEMBL6594186 0.87 MEN1 (0.72) ALDH1A1KDM4EKMT2AMEN1POLB
SCHEMBL6594182 0.87 MEN1 (0.72) ALDH1A1KDM4EKMT2AMEN1POLB
SCHEMBL6591484 0.85 PSD (0.73) ALDH1A1KDM4EKMT2AMEN1POLB
SCHEMBL6591480 0.85 PSD (0.73) ALDH1A1KDM4EKMT2AMEN1POLB
SCHEMBL6597397 0.85 MEN1 (0.77) ALDH1A1KDM4EKMT2AMEN1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004016271-A1 PYRIMIDONES AS ANTIVIRAL AGENTS AXXIMA PHARMACEUTICALS AG (DE) 2004-02-26 WO claimed
EP-1389461-A1 Pyrimidones with antiviral properties Axxima Pharmaceuticals Aktiengesellschaft (DE) 2004-02-18 EP claimed
EP-1412349-A2 PIPERAZINE OXYQUINOLINE (NAPHTHALINE) PLATELET ADENOSINE DIPHOSPHATE RECEPTOR ANTAGONISTS Schering Aktiengesellschaft (DE) 2004-04-28 EP disclosed
WO-2004016271-A1 PYRIMIDONES AS ANTIVIRAL AGENTS AXXIMA PHARMACEUTICALS AG (DE) 2004-02-26 WO disclosed
EP-1389461-A1 Pyrimidones with antiviral properties Axxima Pharmaceuticals Aktiengesellschaft (DE) 2004-02-18 EP disclosed
WO-2002098856-A2 PIPERAZINE OXYQUINOLINE (NAPHTHALINE) PLATELET ADENOSINE DIPHOSPHATE RECEPTOR ANTAGONISTS SCHERING AKTIENGESELLSCHAFT (DE) 2002-12-12 WO disclosed